vimarsana.com
Home
Live Updates
Brii Bio Presents New Data on BRII-835 (VIR-2218) in Chinese
Brii Bio Presents New Data on BRII-835 (VIR-2218) in Chinese
Brii Bio Presents New Data on BRII-835 (VIR-2218) in Chinese Patients with Chronic Hepatitis B at APASL 2022
/PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for...
Related Keywords
Beijing ,
China ,
Seoul ,
Soult Ukpyolsi ,
South Korea ,
Chinese ,
Brii Bio ,
Jidong Jia ,
Li Yan ,
Liver Research Centre At Beijing Friendship Hospital ,
Vir Biotechnology Inc ,
Brii Biosciences ,
Capital Medical University ,
Professor Of Medicine At Capital Medical University ,
Liver Research Centre ,
Brii Biosciences Limited ,
Asian Pacific Association ,
Beijing Friendship Hospital ,
Chief Medical Officer ,
Presentation Title ,
Enhanced Stabilization Chemistry Plus ,
Vir Biotechnology ,